Search Results - "Doble, Brett"

Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms by Doble, Brett, Lorgelly, Paula

“…Purpose To determine the external validity of existing mapping algorithms for predicting EQ-5D-3L utility values from EORTC QLQ-C30 responses and to establish…”
Get full text

Randomized trial evaluating the effectiveness of within versus across-category front-of-package lower-calorie labelling on food demand by Finkelstein, Eric Andrew, Ang, Felicia Jia Ler, Doble, Brett

“…Several front-of-pack (FOP) labels identify healthier options by comparing foods within product categories. Alternative approaches label healthier options by…”
Get full text

A Randomized Controlled Trial Evaluating the Relative Effectiveness of the Multiple Traffic Light and Nutri-Score Front of Package Nutrition Labels by Finkelstein, Eric A, Ang, Felicia Jia Ler, Doble, Brett, Wong, Wei Han Melvin, van Dam, Rob M

“…The objective of this trial was to test two promising front-of-pack nutrition labels, 1) the United Kingdom's Multiple Traffic Lights (MTL) label and 2)…”
Get full text

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis by Tan, Aaron C., Lai, Gillianne G.Y., Tan, Gek San, Poon, Shou Yu, Doble, Brett, Lim, Tse Hui, Aung, Zaw Win, Takano, Angela, Tan, Wan Ling, Ang, Mei-Kim, Tan, Bien Soo, Devanand, Anantham, Too, Chow Wei, Gogna, Apoorva, Ong, Boon-Hean, Koh, Tina P.T., Kanesvaran, Ravindran, Ng, Quan Sing, Jain, Amit, Rajasekaran, Tanujaa, Lim, Alvin S.T., Lim, Wan Teck, Toh, Chee Keong, Tan, Eng-Huat, Lim, Tony Kiat Hon, Tan, Daniel S.W.

“…•Upfront NGS is feasible and cost-effective in an EGFR mutant predominant population.•Characterizing the wider genomic profile may yield important…”
Get full text

Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective by Doble, Brett, MSc, Blackhouse, Gord, MSc, Goeree, Ron, MA, Xie, Feng, PhD

“…Objectives The primary analysis estimated the cost-effectiveness of transfemoral transcatheter aortic valve implantation (Edwards SAPIEN heart valve; Edwards…”
Get full text

Cost-effectiveness of treating relapsed or refractory 3L+ follicular lymphoma with axicabtagene ciloleucel vs mosunetuzumab in the United States by Oluwole, Olalekan O, Ray, Markqayne D, Zur, Richard M, Ferrufino, Cheryl P, Doble, Brett, Patel, Anik R, Bilir, S Pinar

“…Novel therapies for 3L+ relapsed/refractory (r/r) follicular lymphoma (FL) have been approved recently by the US Food and Drug Administration including…”
Get full text

Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies by Harris, Jessica, Pouwels, Koen B, Johnson, Thomas, Sterne, Jonathan, Pithara, Christalla, Mahadevan, Kalaivani, Reeves, Barney, Benedetto, Umberto, Loke, Yoon, Lasserson, Daniel, Doble, Brett, Hopewell-Kelly, Noreen, Redwood, Sabi, Wordsworth, Sarah, Mumford, Andrew, Rogers, Chris, Pufulete, Maria

“…Bleeding among populations undergoing percutaneous coronary intervention or coronary artery bypass grafting and among conservatively managed patients with…”
Get full text

Health-related quality of life impact of minor and major bleeding events during dual antiplatelet therapy: a systematic literature review and patient preference elicitation study by Doble, Brett, Pufulete, Maria, Harris, Jessica M, Johnson, Tom, Lasserson, Daniel, Reeves, Barnaby C, Wordsworth, Sarah

“…Dual antiplatelet therapy (DAPT) is the recommended preventative treatment for secondary ischaemic events, but increases the risk of bleeding, potentially…”
Get full text

Prophylaxis of Radiation-Induced Nausea and Vomiting Using 5-Hydroxytryptamine-3 Serotonin Receptor Antagonists: A Systematic Review of Randomized Trials by Salvo, Nadia, M.Sc.(C.), Doble, Brett, M.Sc.(C.), Khan, Luluel, M.D, Amirthevasar, Gayathri, M.Sc.(C.), Dennis, Kristopher, M.D, Pasetka, Mark, Pharm.D, DeAngelis, Carlo, Pharm.D, Tsao, May, M.D, Chow, Edward, MBBS

“…Purpose To systematically review the effectiveness and safety of 5-hydroxytryptamine-3 receptor antagonists (5-HT3 RAs) compared with other antiemetic…”
Get full text

Reply to the Editor by Doble, Brett, MSc, Xie, Feng, PhD

Get full text

Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling by Miani, Céline, Martin, Adam, Exley, Josephine, Doble, Brett, Wilson, Ed, Payne, Rupert, Avery, Anthony, Meads, Catherine, Kirtley, Anne, Jones, Molly Morgan, King, Sarah

“…To reduce expenditure on, and wastage of, drugs, some commissioners have encouraged general practitioners to issue shorter prescriptions, typically 28 days in…”
Get full text

Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study) by Pufulete, Maria, Harris, Jessica, Sterne, Jonathan A C, Johnson, Thomas W, Lasserson, Daniel, Mumford, Andrew, Doble, Brett, Wordsworth, Sarah, Benedetto, Umberto, Rogers, Chris A, Loke, Yoon, Pithara, Christalla, Redwood, Sabi, Reeves, Barnaby C

“…Introduction‘Real world’ bleeding in patients exposed to different regimens of dual antiplatelet therapy (DAPT) and triple therapy (TT, DAPT plus an…”
Get full text

Budget impact and cost-effectiveness: can we afford precision medicine in oncology? by Doble, Brett

“…Over the past decade there have been remarkable advancements in the understanding of the molecular underpinnings of malignancy. Methods of testing capable of…”
Get full text

Comment on: systematic assessment of decision analytic models for the cost-effectiveness of bariatric surgery for morbid obesity by Doble, Brett

Get full text

Economic Evaluation Alongside a Randomized Controlled Crossover Trial of Modified Group Cognitive–Behavioral Therapy for Anxiety Compared to Treatment-as-Usual in Adults With Asperger Syndrome by Doble, Brett, Langdon, Peter E., Shepstone, Lee, Murphy, Glynis H., Fowler, David, Heavens, David, Malovic, Aida, Russell, Alexandra, Rose, Alice, Mullineaux, Louise, Wilson, Edward C. F.

“…Background: There is a growing interest in using group cognitive–behavioral therapy (CBT) with people who have Asperger syndrome (AS) and comorbid mental…”
Get full text

Comparing EQ-5D Valuation Studies: A Systematic Review and Methodological Reporting Checklist by Xie, Feng, Gaebel, Kathryn, Perampaladas, Kuhan, Doble, Brett, Pullenayegum, Eleanor

“…Background. There has been a growing interest around the world in developing country-specific scoring algorithms for the EQ-5D. This study systematically…”
Get full text

Report of the Lancet Commission on the Value of Death: bringing death back into life by Sallnow, Libby, Smith, Richard, Ahmedzai, Sam H, Bhadelia, Afsan, Chamberlain, Charlotte, Cong, Yali, Doble, Brett, Dullie, Luckson, Durie, Robin, Finkelstein, Eric A, Guglani, Sam, Hodson, Melanie, Husebø, Bettina S, Kellehear, Allan, Kitzinger, Celia, Knaul, Felicia Marie, Murray, Scott A, Neuberger, Julia, O'Mahony, Seamus, Rajagopal, M R, Russell, Sarah, Sase, Eriko, Sleeman, Katherine E, Solomon, Sheldon, Taylor, Ros, Tutu van Furth, Mpho, Wyatt, Katrina

“…Climate change, the COVID-19 pandemic, environmental destruction, and attitudes to death in high-income countries have similar roots—our delusion that we are…”
Get full text

Cost-Effectiveness of Axicabtagene Ciloleucel Versus Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma in the US by Oluwole, Olalekan O., Ray, Markqayne D, Zur, Richard, Little, Aurelia, Ferrufino, Cheryl, Doble, Brett, Patel, Anik R, Bilir, Pinar

“…Introduction Anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapies, including axicabtagene ciloleucel (axi-cel), and CD20 × CD3 T-cell-engaging…”
Get full text

End-of-life cost trajectories and the trade-off between treatment costs and life-extension: Findings from the Cost and Medical Care of Patients with Advanced Serious Illness (COMPASS) cohort study by Doble, Brett, Wong, Wei Han Melvin, Finkelstein, Eric

“…Background: Few studies have assessed how patient preferences influence end-of-life costs. Aim: To estimate mean monthly healthcare costs in 2019 Singapore…”
Get full text

The association of self-blame with treatment preferences in a multi-country cohort of advanced cancer patients from the APPROACH study by Doble, Brett, Lau, Eden, Malhotra, Chetna, Ozdemir, Semra, Teo, Irene, Finkelstein, Eric A.

“…To understand the prevalence of behavioral and characterological self-blame and their associations with stated preferences for life-extension and the use of…”
Get full text